Vical Incorporated Sample Contracts

VICAL INCORPORATED and , As Warrant Agent FORM OF PREFERRED STOCK WARRANT AGREEMENT Dated As Of
Vical Incorporated • May 27th, 2015 • Vical Inc • Biological products, (no disgnostic substances) • New York

PREFERRED STOCK WARRANT AGREEMENT (the “Agreement”), dated as of between VICAL INCORPORATED, a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
As Warrant Agent FORM OF PREFERRED STOCK WARRANT AGREEMENT Dated As Of
Vical Incorporated • May 25th, 2018 • Vical Inc • Biological products, (no disgnostic substances) • New York

PREFERRED STOCK WARRANT AGREEMENT (the “Agreement”), dated as of between VICAL INCORPORATED, a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

Sample 1Sample 2
VICAL INCORPORATED Common Stock (par value $0.01 per share) At-The-Market Issuance Sales Agreement
Vical Incorporated • October 17th, 2016 • Vical Inc • Biological products, (no disgnostic substances) • New York

Vical Incorporated, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with IFS Securities, Inc. (doing business as Brinson Patrick, a division of IFS Securities, Inc. (“BP”), as follows:

Sample 1Sample 2
VICAL INCORPORATED Common Stock ($0.01 par value per share) AT-THE-MARKET EQUITY OFFERING SALES AGREEMENT
Vical Incorporated • November 7th, 2012 • Vical Inc • Biological products, (no disgnostic substances) • New York

Vical Incorporated, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time to or through Stifel, Nicolaus & Company, Incorporated (“Stifel Nicolaus”), as sales agent and/or principal (“Agent”), shares (the “Shares”) of the Company’s common stock, $0.01 par value per share (the “Common Stock”), having an aggregate offering price of up to $50,000,000 (the “Maximum Offering Size”) on the terms set forth in Section 2 of this At-the-Market Equity Offering Sales Agreement (the “Agreement”). The Company agrees that whenever it determines to sell Shares directly to the Agent as principal, it will enter into a separate agreement (each, a “Terms Agreement”) in substantially the form of Annex I hereto, relating to such sale in accordance with Section 3 of this Agreement. The foregoing notwithstanding, the Company shall not issue or sell pursuant to this Agreement an aggregate amount of Common Stock that would cause

Sample 1
VICAL INCORPORATED COMMON STOCK PURCHASE AGREEMENT
Vical Incorporated • July 28th, 2009 • Vical Inc • Biological products, (no disgnostic substances) • New York

THIS COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of the 27th day of July, 2009, by and among Vical Incorporated, a Delaware corporation (the “Company”), and the investors set forth on the signature pages hereto (the “Investors”).

Sample 1
As Warrant Agent FORM OF DEBT SECURITIES WARRANT AGREEMENT Dated As Of
Vical Incorporated • May 25th, 2018 • Vical Inc • Biological products, (no disgnostic substances) • New York

DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between VICAL INCORPORATED, a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

Sample 1
VICAL INCORPORATED [2,500,000 SHARES (*)] COMMON STOCK UNDERWRITING AGREEMENT
Vical Incorporated • December 16th, 1999 • Vical Inc • Biological products, (no disgnostic substances) • New York
Sample 1
Time is Money Join Law Insider Premium to draft better contracts faster.